MIST News and Press, Milestone Pharmaceuticals Inc. From 04/02/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Canadian pharma small-cap Milestone Pharmaceuticals (NASDAQ: MIST ) has had a tumultuous ride since shares starting trading nearly two years ago. MIST stock was soon going for over $27. It dropped below $2 a share a y...

Milestone Pharmaceuticals (MIST): Q4 GAAP EPS of -$0.23 beats by $0.18.As of December 31, 2020, Milestone had cash, cash equivalents, and short-term investments of $142.3M.Press Release For further details see: Milestone Pharmaceuticals EPS beats by $0.18

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update PR Newswire MONTREAL and CHARLOTTE, N.C., March 29, 2021 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a b...

4 Health Care Stocks To Consider Buying In March Health care is one of the most important sectors in the world today. They are one of the largest and most complex sectors, with a broad range of companies that sell medical products and services. Investors are watching the health care...

Milestone Pharmaceuticals (MIST) pivotal Phase 3 study of etripamil nasal spray for the treatment of patients with paroxysmal supraventricular tachycardia ((PSVT)) is now underway.Etripamil, under development as a nasal spray, is a short-acting calcium channel blocker for patients with p...

Milestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal Phase 3 Study of Etripamil in PSVT PR Newswire MONTREAL and CHARLOTTE, N.C., Nov. 18, 2020 – RAPID and completed NODE-301 studies could potentially fulfill efficacy requireme...

Milestone Pharmaceuticals (MIST): Q3 GAAP EPS of -$0.40 beats by $0.09.As of September 30, 2020, Milestone had cash, cash equivalents, and short-term investments of $102.9 million, 24.7 million shares outstanding and 6.7 million pre-funded warrants outstanding.Press Release For further deta...

Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate Update PR Newswire MONTREAL and CHARLOTTE, N.C., Nov. 13, 2020 MONTREAL and CHARLOTTE, N.C., Nov. 13, 2020 /PRNewswire/ -- Milestone Pharmaceutica...

Milestone Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference Canada NewsWire MONTREAL and CHARLOTTE, N.C., Nov. 11, 2020 MONTREAL and CHARLOTTE, N.C., Nov. 11, 2020 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq:...

Gainers: Cassava Sciences (SAVA) +13%, Medigus (MDGS) +10%, STRATA Skin Sciences (SSKN) +9%, CASI Pharmaceuticals (CASI) +8%, BOQI International Medical (BIMI) +7%.Losers: Neovasc (NVCN) -14%, ProPhase Labs (PRPH) -14%, Mileston...